Notable Reporting: Perrigo Co PLC (NYSE:PRGO) Stock Price Down as Sentiment Worsens

November 28, 2016 - By Clifton Ray   ·   0 Comments

Notable Reporting: Perrigo Co PLC (NYSE:PRGO) Stock Price Down as Sentiment  Worsens

Sentiment for Perrigo Co PLC (NYSE:PRGO)

Perrigo Co PLC (NYSE:PRGO) institutional sentiment decreased to 0.77 in Q2 2016. Its down -0.04, from 0.81 in 2016Q1. The ratio dropped, as 222 investment managers opened new and increased positions, while 275 trimmed and sold stock positions in Perrigo Co PLC. The investment managers in our partner’s database reported: 86.20 million shares, down from 98.38 million shares in 2016Q1. Also, the number of investment managers holding Perrigo Co PLC in their top 10 positions decreased from 9 to 7 for a decrease of 2. Sold All: 102 Reduced: 173 Increased: 142 New Position: 80.

The stock decreased 1.67% or $1.49 on November 25, hitting $87.84. Perrigo Company plc Ordinary Shares (NYSE:PRGO) has declined 11.63% since April 25, 2016 and is downtrending. It has underperformed by 17.64% the S&P500.

Analysts await Perrigo Company plc Ordinary Shares (NYSE:PRGO) to report earnings on February, 16. They expect $1.67 EPS, down 7.22% or $0.13 from last year’s $1.8 per share. PRGO’s profit will be $239.36M for 13.15 P/E if the $1.67 EPS becomes a reality. After $1.65 actual EPS reported by Perrigo Company plc Ordinary Shares for the previous quarter, Wall Street now forecasts 1.21% EPS growth.

According to Zacks Investment Research, “Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.”

Accipiter Capital Management Llc holds 15.24% of its portfolio in Perrigo Company plc Ordinary Shares for 205,636 shares. North Run Capital Lp owns 465,000 shares or 6.95% of their US portfolio. Moreover, North Tide Capital Llc has 5.05% invested in the company for 500,000 shares. The Pennsylvania-based Symons Capital Management Inc has invested 4.75% in the stock. Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management), a Israel-based fund reported 529,456 shares.#img1#

Perrigo Company plc Ordinary Shares (NYSE:PRGO) Ratings Coverage

Ratings analysis reveals 27% of Perrigo Company Plc’s analysts are positive. Out of 15 Wall Street analysts rating Perrigo Company Plc, 4 give it “Buy”, 1 “Sell” rating, while 10 recommend “Hold”. The lowest target is $84 while the high is $241. The stock’s average target of $128.45 is 46.23% above today’s ($87.84) share price. PRGO was included in 35 notes of analysts from October 23, 2015. JP Morgan reinitiated the stock with “Neutral” rating in Wednesday, November 18 report. The rating was maintained by Jefferies with “Hold” on Thursday, August 11. The stock has “Neutral” rating given by Bank of America on Friday, November 11. The firm earned “Hold” rating on Monday, April 25 by Stifel Nicolaus. The company was maintained on Tuesday, April 26 by Barclays Capital. The stock of Perrigo Company plc Ordinary Shares (NYSE:PRGO) has “Sell” rating given on Monday, February 22 by Goldman Sachs. The stock of Perrigo Company plc Ordinary Shares (NYSE:PRGO) earned “Hold” rating by Jefferies on Tuesday, April 26. The company was initiated on Thursday, January 21 by Barclays Capital. The firm has “Buy” rating by B. Riley & Co given on Wednesday, November 18. The stock of Perrigo Company plc Ordinary Shares (NYSE:PRGO) has “Buy” rating given on Thursday, August 11 by Deutsche Bank.

PRGO Company Profile

Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, incorporated on June 28, 2013, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company’s divisions include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences and Other. The Firm makes OTC healthcare products and supplies infant formulas for the store brand market. It is also a well-known provider of generic extended topical prescription products. It provides healthcare products across a range of product categories and geographies, primarily in North America, Europe and Australia, as well as in other markets, including Israel and China.

More recent Perrigo Company plc Ordinary Shares (NYSE:PRGO) news were published by: Fool.com which released: “Why Perrigo Company PLC Ordinary Shares Are Dropping Today” on April 25, 2016. Also Fool.com published the news titled: “Why Perrigo Company PLC Ordinary Shares Are Plummeting Today” on February 18, 2016. Investorplace.com‘s news article titled: “3 Stocks to Watch Monday: Tesla Motors Inc (TSLA), Perrigo Company plc …” with publication date: September 12, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Clifton Ray

Tags: , ,


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>